Society for Immunotherapy of Cancer (SITC) shared a post on LinkedIn:
“Join the upcoming scientific workshop organized in collaboration between the American Society of Hematology and the Society for Immunotherapy of Cancer exploring how host biology influences the efficacy and toxicity of cell and gene therapies. Expert speakers will share recent findings, discuss clinical implications, and outline strategies to optimize outcomes in both hematologic and solid tumor applications.
Date and Time: Friday, December 5, 2025 | 3–6 p.m.
Location: Orlando, Florida — held in conjunction with the ASH Annual Meeting
More posts about SITC.